Oncology Impact Fund (Cayman) Management L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 172,231 shares at $29.18 ($4.1M) on 2021-09-07, disclosed to the SEC on 2021-09-08.
Open-market sale of $4.1M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 31,340 | $0 | 0.0% |
| 2 | $29.18 | 50,996 | $1.5M | 36.4% |
| 3 | $29.18 | 50,996 | $1.5M | 36.4% |
| 4 | $28.61 | 18,663 | $534K | 13.1% |
| 5 | $28.61 | 18,663 | $534K | 13.1% |
| 6 | $29.10 | 1,573 |
| $46K |
| 1.1% |
| Total | $23.75 avg | 172,231 | $4.1M | 100% |
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |